Brandinium

Trademark search for:

SENSIMIST

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2014-10-17 — Application filed
  • 2014-10-22 — Application filed
  • 2014-10-29 — Application filed
  • 2014-10-30 — Notice of pseudo mark e-mailed
  • 2015-01-10 — Approved for pub - principal register
  • 2015-01-10 — Assigned to examiner
  • 2015-01-28 — Notification of notice of publication e-mailed
  • 2015-02-17 — Published for opposition
  • 2015-02-17 — Official gazette publication confirmation e-mailed
  • 2015-03-18 — Extension of time to oppose received
  • 2015-08-11 — Teas post publication amendment received
  • 2015-08-21 — Assigned to petition staff
  • 2015-08-26 — Post publication amendment - entered
  • 2015-09-01 — Extension of time to oppose process - terminated
  • 2015-10-13 — Noa e-mailed - sou required from applicant
  • 2016-04-12 — Sou teas extension received
  • 2016-04-12 — Sou extension 1 filed
  • 2016-04-12 — Sou extension 1 granted
  • 2016-04-14 — Notice of approval of extension request e-mailed
  • 2016-09-30 — Sou teas extension received
  • 2016-09-30 — Sou extension 2 filed
  • 2016-10-25 — Case assigned to intent to use paralegal
  • 2016-10-25 — Sou extension 2 granted
  • 2016-10-26 — Notice of approval of extension request e-mailed
  • 2017-02-21 — Sou teas extension received
  • 2017-02-21 — Teas statement of use received
  • 2017-02-21 — Use amendment filed
  • 2017-02-21 — Sou extension 3 filed
  • 2017-03-13 — Case assigned to intent to use paralegal
  • 2017-03-22 — Statement of use processing complete
  • 2017-03-22 — Sou extension 3 granted
  • 2017-03-23 — Allowed principal register - sou accepted
  • 2017-03-23 — Notice of approval of extension request e-mailed
  • 2017-03-24 — Notice of acceptance of statement of use e-mailed
  • 2017-04-25 — Registered-principal register
  • 2020-08-03 — Attorney/dom.rep.revoked and/or appointed
  • 2020-08-03 — Teas withdrawal as domestic representative received
  • 2020-08-03 — Teas change of owner address received
  • 2020-08-03 — Teas change of correspondence received
  • 2020-08-03 — Applicant/correspondence changes (non-responsive) entered
  • 2020-08-03 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-08-03 — Teas withdrawal of attorney received-firm retains
  • 2021-04-07 — Attorney/dom.rep.revoked and/or appointed
  • 2021-04-07 — Teas change of correspondence received
  • 2021-04-07 — Teas revoke/app/change addr of atty/dom rep received
  • 2021-04-07 — Teas withdrawal of attorney received-firm retains
  • 2022-04-25 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2022-11-09 — Attorney/dom.rep.revoked and/or appointed
  • 2022-11-09 — Teas change of owner address received
  • 2022-11-09 — Teas change of correspondence received
  • 2022-11-09 — Applicant/correspondence changes (non-responsive) entered
  • 2022-11-09 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-05-17 — Automatic update of assignment of ownership
  • 2023-11-10 — Cancelled sec. 8 (6-yr)
  • 2023-11-10 — Final status recorded
  • 2024-01-17 — Assignment of ownership not updated automatically

Owner Information

GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED
WEYBRIDGE, SURREY
Glaxo Group Limited
Greenford, Middlesex GB
Glaxo Group Limited
Greenford, Middlesex
Glaxo Group Limited
Greenford, Middlesex

Correspondent

Arrielle S. Siolos Haleon
184 Liberty Corner Road
WNJ0200
Warren, NJ 07059

Filing Details

Filing Date:
2014-10-17
Status Date:
2023-11-10
Category:
Pharmaceuticals
Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.